This activity is expired and is no longer available for CME credit.


Treatment Guidelines for RA 2017: Implementation and Controversies for Efficacy and Safety

Author(s)/Faculty: Leonard H. Calabrese, DO
Release Date: 10/31/2017Expiration Date: 10/30/2018
Credit Type: CMENumber of Credits: 0
Content Type: ArticleProvider:
Rheumatoid arthritis (RA) is a progressive and painful systemic inflammatory disease that preferentially attacks the synovium of the joints, leading to joint destruction, debility, and deformity. Increased understanding of the underlying pathophysiology of RA has made a remarkable difference in its treatment and prognosis. Numerous therapeutic agents with diverse targets and mechanisms have been added to the RA armamentarium, allowing for intervention at various stages in the pathogenic process of the disease. This activity will review treatment guidelines for RA in 2017.